Bastide le Confort Medical (BLC) AI Stock Analysis

• Market Cap: €191.60M
• Dividend Yield: N/A
• Average Volume (3M): 5.76K
• Price to Earnings (P/E): 368.0
• Beta (1Y): 0.89
• Revenue Growth: -7.28%
• EPS Growth: N/A
• Country: FR
• Employees: 3,635
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Distribution
• EPS (TTM): -0.01
• Shares Outstanding: 7,365,078
• 10 Day Avg. Volume: 5,209
• 30 Day Avg. Volume: 5,758
• PEG Ratio: -2.78
• Price to Book (P/B): 3.24
• Price to Sales (P/S): 0.48
• P/FCF Ratio: 5.60
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 49 Neutral
• Price Target: €22.00 ▼(-7.76% Downside)
• Action: Reiterated Date: 12/11/25
• Date: Action: Reiterated 12/11/25

The overall stock score is primarily impacted by financial performance challenges, including high leverage and declining revenue growth. Technical analysis indicates bearish momentum, and the stock appears overvalued based on its P/E ratio. These factors collectively result in a lower score.

Positive Factors

Operational margins

High gross and EBITDA margins indicate efficient procurement and operational processes that create durable cash generation capacity. Sustained margin structure provides a buffer against revenue volatility, funds for reinvestment in services and devices, and supports long-term service profitability.

Free cash flow generation

Very strong free cash flow growth and solid cash conversion ratios (operating cash flow to net income ~0.51, FCF to net income ~0.41) enhance financial flexibility. Robust FCF supports debt servicing, maintenance capex, and investment in recurring-service capabilities over the medium term.

Recurring revenue mix

A business model built on rentals, service contracts and referrals creates recurring revenue and customer stickiness. This durable revenue base smooths cash flows, enables cross-sell of equipment and services, and supports long-term unit economics even if new sales slow.

Negative Factors

High financial leverage

Very high leverage raises interest and refinancing risk and constrains strategic flexibility. In a capital-intensive home-health model this amplifies downside if revenues decline, increases covenant vulnerability, and limits ability to fund growth without deleveraging.

Declining revenue trend

Sustained revenue declines suggest demand or market-share pressures that hurt scale economics. Falling top-line undermines margin recovery, strains cash generation relative to fixed costs, and makes deleveraging and profitable reinvestment more difficult over the next several quarters.

Very low net profitability

Extremely low net margin and ROE show limited capacity to convert sales into shareholder returns. Combined with high leverage, this constrains retained earnings and makes it harder to self-fund growth or absorb shocks without operational improvement or capital restructuring.

Bastide le Confort Medical Business Overview & Revenue Model

Company Description

Bastide Le Confort Médical SA engages in the sale and rental of medical equipment in France. The company offers comfort and health products, such as lift chairs, bathroom and well-being products, pillows and cushions, seats, phones keys, measuring devices, technical aids, fitness products, blood pressure monitors, and pillboxes ; and incontinence products, including absorbent and support briefs, anatomical protections, protections for men and women, disposable mattress pads, PVC panties, and hygiene and body care products. It also provides medical materials comprising home support products wheel chairs, electric scooters, walkers, bed tables and rails, and transfer aids, air mattress, sick lifts, and standers; and medical equipment consisting of consumables, care and dressings, hygiene and disinfection products, outfits and briefcases, and other medical equipment, as well as home support services for elderly, senior, or disabled. It offers its products through approximately 130 stores, as well as through an online store. The company was founded in 1977 and is headquartered in Caissargues, France.

How the Company Makes Money

Bastide le Confort Medical generates revenue through multiple key streams, including the sale of medical equipment and supplies, as well as home healthcare services. The company earns significant income from direct sales to consumers and healthcare institutions, alongside rental agreements for medical devices. Additionally, BLC has established partnerships with healthcare professionals and institutions that facilitate referrals and enhance service offerings. Their focus on providing comprehensive home care solutions allows for recurring revenue through ongoing service contracts and maintenance agreements, contributing to stable financial performance.

Bastide le Confort Medical Financial Statement Overview

Summary

Bastide le Confort Medical exhibits strengths in operational efficiency and cash flow management, with solid gross and EBITDA margins and strong free cash flow growth. However, challenges include declining revenue growth, low net profit margins, and high financial leverage.

Income Statement

Bastide le Confort Medical shows a strong gross profit margin of approximately 68%, indicating efficient cost management. However, the net profit margin is extremely low at 0.1%, reflecting challenges in converting revenue into profit. The revenue growth rate is negative at -9.1%, suggesting a decline in sales performance. Despite these challenges, the company maintains a stable EBIT margin of 8.4% and an EBITDA margin of 20.8%, highlighting operational efficiency.

Balance Sheet

The company has a high debt-to-equity ratio of 5.7, indicating significant leverage and potential financial risk. Return on equity is very low at 0.7%, suggesting limited profitability for shareholders. The equity ratio is also low, reflecting a reliance on debt financing. These factors suggest a need for improved financial stability and risk management.

Cash Flow

Bastide le Confort Medical demonstrates strong cash flow performance with a significant free cash flow growth rate of 178.6%. The operating cash flow to net income ratio is 0.51, indicating good cash generation relative to net income. The free cash flow to net income ratio is 0.41, showing a healthy conversion of earnings into cash. These metrics reflect robust cash flow management despite the company's profitability challenges.

Breakdown	Sep 2025	Sep 2024	Jun 2023	Sep 2022	Jun 2021
Income Statement
Total Revenue	491.18M	529.75M	508.03M	468.30M	444.07M
Gross Profit	333.00M	354.44M	333.73M	306.80M	280.26M
EBITDA	102.03M	107.20M	98.15M	89.83M	88.30M
Net Income	528.00K	-900.00K	12.05M	13.68M	13.45M
Balance Sheet
Total Assets	661.03M	647.07M	657.08M	632.55M	569.11M
Cash, Cash Equivalents and Short-Term Investments	25.49M	23.62M	36.71M	22.13M	33.74M
Total Debt	411.16M	408.65M	427.39M	419.23M	357.62M
Total Liabilities	589.73M	566.34M	568.99M	545.89M	484.05M
Stockholders Equity	72.13M	79.77M	87.65M	84.56M	81.31M
Cash Flow
Free Cash Flow	41.74M	10.64M	36.65M	-6.51M	19.62M
Operating Cash Flow	101.82M	66.04M	90.28M	46.76M	66.13M
Investing Cash Flow	-56.44M	-43.65M	-76.27M	-104.74M	-73.45M
Financing Cash Flow	-4.33M	-35.55M	-7.89M	29.43M	1.34M

Bastide le Confort Medical Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 23.85
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:BLC, the sentiment is Positive. The current price of 23.85 is above the 20-day moving average (MA) of 23.62, below the 50-day MA of 24.12, and below the 200-day MA of 26.41, indicating a neutral trend. The MACD of 0.41 indicates Negative momentum. The RSI at 70.68 is Negative, neither overbought nor oversold. The STOCH value of 83.98 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:BLC.

Bastide le Confort Medical Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
LNA	61 Neutral	€267.80M	12.97	6.64%	2.73%	13.31%	-13.07%
ALERS	55 Neutral	€231.63M	98.68	1.32%	―	12.47%	-65.87%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
BLC	49 Neutral	€191.60M	367.98	3.97%	―	-7.28%	―